Off the wire
Hong Kong stocks close 0.74 pct lower  • Malaysia issues arrest warrant for Air Koryo staff over airport killing  • Top news items in major Kenyan media outlets  • Foreign exchange rates in India  • Hormone predicts death, problems in heart patients: New Zealand scientists  • U.S. bentonite eyes East Asia for kitty litter market  • Police seize arms, ammunition from vehicle in N. Afghan province  • 2nd LD-Writethru: Caixin service PMI slips to 52.6  • Private investment highlighted at annual advisory session  • New Zealand military surrenders HQ to earthquake damage  
You are here:   Home

Russian scientists successfully test cancer-killing drug in space

Xinhua, March 3, 2017 Adjust font size:

Russian scientists have successfully tested a cancer-killing drug in space, which can fight all kinds and stages of malignant tumors in the human body, the local newspaper Izvestia cited a professor as saying on Friday.

"The drug is named as 'thermal shock protein,' based on the main active ingredient," said Professor Andrei Simbirtsev, Deputy Director of the Scientific Research Institute of Highly Pure Biologic Treatments of the Russian Federal Medical & Biological Agency.

Simbirtsev said that the protein not only protects human cells from damage but also helps cells reveal their tumor antigens to the immune system, thus strengthening the immune response.

The protein exists in the human body in minimal amounts. However, the gene responsible for its production has been identified by Russian scientists. They have created a bacterial cell that can produce the protein.

"Such bacterial cells multiply well, which allowed us to obtain unlimited amounts of the protein," Simbirtsev said.

The new drug has been tested on mice and rats with melanoma and sarcoma, the results showed that there is a complete recovery even in the later stage in the majority of the cases.

Another year is needed to complete preclinical trials to help confirm the new drug has zero toxicity, said the professor. Endi